International trade · 14/08/2017

Bioverativ Inc. Files Complaint with U.S. International Trade Commission Over Recombinant Factor IX Products

Bioverativ Inc. has filed a complaint with the U.S. International Trade Commission alleging that certain recombinant Factor IX products infringe on three U.S. patents and requesting the Commission to institute an investigation and issue exclusion orders